Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor superfamily and mediates the biological effects of peroxisome proliferators. To determine the physiological role of PPARalpha in cardiac fatty acid metabolism, we examined the regulation of expression of cardiac fatty acid-metabolizing proteins using PPARalpha-null mice. The capacity for constitutive myocardial beta-oxidation of the medium and long chain fatty acids, octanoic acid and palmitic acid, was markedly reduced in the PPARalpha-null mice as compared with the wild-type mice, indicating that mitochondrial fatty acid catabolism is impaired in the absence of PPARalpha. In contrast, constitutive beta-oxidation of the very long chain fatty acid, lignoceric acid, did not differ between the mice, suggesting that the constitutive expression of enzymes involved in peroxisomal beta-oxidation is independent of PPARalpha(.) Indeed, PPARalpha-null mice had normal levels of the peroxisomal beta-oxidation enzymes except the D-type bifunctional protein. At least seven mitochondrial fatty acid-metabolizing enzymes were expressed at much lower levels in the PPARalpha-null mice, whereas other fatty acid-metabolizing enzymes were present at similar or slightly lower levels in the PPARalpha-null, as compared with wild-type mice. Additionally, lower constitutive mRNA expression levels of fatty acid transporters were found in the PPARalpha-null mice, suggesting a role for PPARalpha in fatty acid transport and catabolism. Indeed, in fatty acid metabolism experiments in vivo, myocardial uptake of iodophenyl 9-methylpentadecanoic acid and its conversion to 3-methylnonanoic acid were reduced in the PPARalpha-null mice. Interestingly, a decreased ATP concentration after exposure to stress, abnormal cristae of the mitochondria, abnormal caveolae, and fibrosis were observed only in the myocardium of the PPARalpha-null mice. These cardiac abnormalities appeared to proceed in an age-dependent manner. Taken together, the results presented here indicate that PPARalpha controls constitutive fatty acid oxidation, thus establishing a role for the receptor in cardiac fatty acid homeostasis. Furthermore, altered expression of fatty acid-metabolizing proteins seems to lead to myocardial damage and fibrosis, as inflammation and abnormal cell growth control can cause these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cardiac specific knockout of PPARα causes deficiencies in mitochondrial β-oxidation, leading to eventual myocardial damage and fibrosis [113].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationPeroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Self-citationThe PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Self-citationActivation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., & Grimaldi, P. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46753-6 · Cited by 1,002
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
Schaffer, J. E., & Lodish, H. F. (1994) · Cell · doi:10.1016/0092-8674(94)90252-6 · Cited by 872
Research works printed but not linked: 4
- 9. Chouraqui, P. ∙ Maddahi, J. ∙ Henkin, R. ... J. Nucl. Med. 1991; 32:447-452 PubMed Google Scholar
- Lefer, 1985, Fed. Proc., 44, 275
- Lefer, 1987, Arch. Int. Pharm. Ther., 287, 89
- Lefer, 1987, Cardiovasc. Clin., 18, 85
Cited by
Items 101–200 of 330
Slater-Jefferies, J. L., Lillycrop, K. A., Townsend, P. A., Torrens, C., Hoile, S. P., Hanson, M. A., & Burdge, G. C. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000425 · Cited by 69
Warren, J. S., Oka, S., Zablocki, D., & Sadoshima, J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00103.2017 · Cited by 69
HOLNESS, M. J., SMITH, N. D., BULMER, K., HOPKINS, T., GIBBONS, G. F., & SUGDEN, M. C. (2002) · Biochemical Journal · doi:10.1042/bj20011841 · Cited by 63
Djouadi, F., Bonnefont, J., Thuillier, L., Droin, V., Khadom, N., Münnich, A., & Bastin, J. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000083001.91588.bb · Cited by 69
Exercise and Regulation of Lipid Metabolism
Noland, R. C. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.06.017 · Cited by 68
Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop
Colasante, C., Chen, J., Ahlemeyer, B., & Baumgart‐Vogt, E. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0497 · Cited by 71
Howroyd, P., Swanson, C., Dunn, C., Cattley, R. C., & Corton, J. C. (2004) · Toxicologic Pathology · doi:10.1080/01926230490515283 · Cited by 65
Kong, L., Ren, W., Li, W., Zhao, S., Mi, H.-M., Wang, R., Zhang, Y., Wu, W., Nan, Y., & Yu, J. Q. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-246 · Cited by 67
Duhaney, T.-A. S., Cui, L., Rude, M. K., LeBrasseur, N. K., Ngoy, S., Silva, D. S. D., Siwik, D. A., Liao, R., & Sam, F. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086926 · Cited by 67
Rotkvić, P. G., Planinić, Z., Pršo, A.-M. L., Šikić, J., Galić, E., & Rotkvić, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115973 · Cited by 66
Azimzadeh, O., Sievert, W., Sarioglu, H., Yentrapalli, R., Barjaktarović, Ž., Sriharshan, A., Ueffing, M., Janik, D., Aichler, M., Atkinson, M. J., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400071g · Cited by 65
The Positive Regulation of eNOS Signaling by PPAR Agonists in Cardiovascular Diseases
Maccallini, C., Mollica, A., & Amoroso, R. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0220-9 · Cited by 65
Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
Khuchua, Z. A., Glukhov, A. I., Strauss, A. W., & Javadov, S. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113464 · Cited by 65
PPARs in Calorie Restricted and Genetically Long-Lived Mice
Masternak, M. M., & Bartke, A. (2007) · PPAR Research · doi:10.1155/2007/28436 · Cited by 61
Li, L., Wu, L., Wang, C., Liu, L., & Zhao, Y. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.10.007 · Cited by 61
Deletion of peroxisome proliferator-activated receptor-α induces an alteration of cardiac functions
Loichot, C., Jesel, L., Tesse, A., Tabernero, A., Schoonjans, K., Roul, G., Carpusca, I., Auwerx, J. H., & Andriantsitohaina, R. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01065.2004 · Cited by 60
Transcriptional Regulation of Postnatal Cardiomyocyte Maturation and Regeneration
Padula, S. L., Velayutham, N., & Yutzey, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063288 · Cited by 62
Duncan, J. G. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9889-8 · Cited by 61
LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling
Gao, L., Liu, Y., Guo, S., Xiao, L., Wu, L., Wang, Z., Liang, C., Yao, R., & Zhang, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.019 · Cited by 59
PPARα attenuates the proinflammatory response in activated mesangial cells
Kono, K., Kamijo, Y., Hora, K., Takahashi, K., Higuchi, M., Kiyosawa, K., Shigematsu, H., Gonzalez, F. J., & Aoyama, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2007 · Cited by 52
Self-citationGao, T., Zhu, Z., Zhou, X., & Xie, M.-L. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1190764 · Cited by 57
FABPs as determinants of myocellular and hepatic fuel metabolism
Binas, B., & Erol, E. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9043-0 · Cited by 56
Lipoprotein lipase activity is required for cardiac lipid droplet production
Trent, C. M., Yu, S., Hu, Y., Skoller, N., Huggins, L. A., Homma, S., & Goldberg, I. J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m043471 · Cited by 55
Legumes as Functional Food for Cardiovascular Disease
Angeles, J. G. C., Villanueva, J. C., Uy, L. Y., Mercado, S. M. Q., Tsuchiya, M. C., Lado, J. P., Angelia, M. R. N., Bercansil, M. C. M. L., Estacio, M. A. C., & Torio, M. A. O. (2021) · Applied Sciences · doi:10.3390/app11125475 · Cited by 56
Okuda, J., Niizuma, S., Shioi, T., Kato, T., Inuzuka, Y., Kawashima, T., Tamaki, Y., Kawamoto, A., Tanada, Y., Iwanaga, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072173 · Cited by 54
PPARs: Protectors or Opponents of Myocardial Function?
Pol, C. J., Lieu, M., & Drosatos, K. (2015) · PPAR Research · doi:10.1155/2015/835985 · Cited by 55
Werbner, B., Tavakoli‐Rouzbehani, O. M., Fatahian, A. N., & Boudina, S. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.42 · Cited by 54
Kamijo, Y., Hora, K., Nakajima, T., Kono, K., Takahashi, K., Ito, Y., Higuchi, M., Kiyosawa, K., Shigematsu, H., Gonzalez, F. J., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060597 · Cited by 53
Self-citationGoikoetxea, M. J., Beaumont, J., González, A., López, B., Querejeta, R., Larman, M., & Díez, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.016 · Cited by 53
Fiaccavento, R., Carotenuto, F., Minieri, M., Masuelli, L., Vecchini, A., Bei, R., Modesti, A., Binaglia, L., Fusco, A., Bertoli, A., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051320 · Cited by 52
Targeting fatty acid metabolism for fibrotic disorders
Hwang, S., & Chung, K. W. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01352-4 · Cited by 50
Ingwall, J. S. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0023-x · Cited by 50
Plummer, S. M., Sharpe, R. M., Hallmark, N., Mahood, I. K., & Elcombe, C. R. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm062 · Cited by 50
Vega, V. A., Anzulovich, A. C., Varas, S. M., Bonomi, M. R., Giménez, M. S., & Oliveros, L. B. (2009) · Nutrition · doi:10.1016/j.nut.2009.01.008 · Cited by 49
Linz, W., Wohlfart, P., Baader, M., Breitschopf, K., Falk, E., Schäfer, H., Gerl, M., Kramer, W., & Rütten, H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.58 · Cited by 50
Kanda, H., Nohara, R., Hasegawa, K., Kishimoto, C., & Sasayama, S. (2000) · Heart and Vessels · doi:10.1007/s003800070022 · Cited by 49
Hauck, L., Stanley-Hasnain, S., Fung, A., Grothe, D., Rao, V., Mak, T. W., & Billia, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189861 · Cited by 48
Diabetes-related metabolic perturbations in cardiac myocyte
Feuvray, D., & Darmellah, A. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)70096-x · Cited by 48
Li, X., Hou, H., Chen, H., Liu, X., Wang, J., Yang, Q., & He, G. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.01.079 · Cited by 47
Fritah, A., Steel, J. H., Nichol, D., Parker, N., Williams, S., Price, A. N., Strauss, L., Ryder, T. A., Mobberley, M. A., POUTANEN, M. H., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp418 · Cited by 48
Chen, W., Xia, Y., Zhao, X., Wang, H., Chen, W., Mao-hua, Y., Li, Y., Ye, H., & Zhang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045541 · Cited by 46
Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases
Bedu, E., Wahli, W., & Desvergne, B. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.861 · Cited by 46
Kalliora, C., & Drosatos, K. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000891 · Cited by 45
Metabolic Therapy at the Crossroad: How to Optimize Myocardial Substrate Utilization?
Kolwicz, S. C., & Tian, R. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.12.005 · Cited by 45
Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease
Barak, Y., & Kim, S. (2007) · PPAR Research · doi:10.1155/2007/12781 · Cited by 41
Sugiyama, E., Ishikawa, Y., Li, Y., Kagai, T., Nobayashi, M., Tanaka, N., Kamijo, Y., Yokoyama, S., Hara, A., & Aoyama, T. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.04.011 · Cited by 43
Self-citationMetabolic Alterations in Inherited Cardiomyopathies
Sacchetto, C., Sequeira, V., Bertero, E., Dudek, J., Maack, C., & Calore, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122195 · Cited by 44
Gopal, K., Karwi, Q. G., Dakhili, S. A. T., Wagg, C. S., Zhang, L., Sun, Q., Saed, C. T., Panidarapu, S., Perfetti, R., Ramasamy, R., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01811-w · Cited by 43
Marionneau, C., Aimond, F., Brunet, S., Niwa, N., Finck, B. N., Kelly, D. P., & Nerbonne, J. M. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.023 · Cited by 43
Nanoparticle conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by regulating PPARα pathway
Zhang, Y., Ji, H., Qiao, O., Li, Z., Pecoraro, L., Zhang, X., Han, X., Wang, W., Zhang, X., Man, S., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111630 · Cited by 42
Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart
Tian, R. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0052-7 · Cited by 42
Azimzadeh, O., Moertl, S., Ramadan, R., Baselet, B., Laiakis, E. C., Sebastian, S., Beaton, D., Hartikainen, J. M., Kaiser, J. C., Beheshti, A., et al. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2110325 · Cited by 40
Sekiguchi, K., Tian, Q., Ishiyama, M., Burchfield, J., Gao, F., Mann, D. L., & Barger, P. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01056.2006 · Cited by 36
Xue, H., Cheng, Y.-J., Wang, X., Yue, Y., Zhang, W., & Li, X. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.07.022 · Cited by 39
Jones, D. C., Manning, B. M., & Daynes, R. A. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002173 · Cited by 39
Transcriptomic analysis of PPARα-dependent alterations during cardiac hypertrophy
Smeets, P., den Bosch, H. D. V.-V., Willemsen, P. H. M., Stassen, A. P. M., Ayoubi, T., Vusse, G. J., & van Bilsen, M. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90296.2008 · Cited by 38
Jia, Y., Chang, H., Schipma, M. J., Liu, J., Shete, V., Liu, N., Sato, T., Thorp, E. B., Barger, P. M., Zhu, Y.-J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160755 · Cited by 38
Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
Arumugam, S., Sreedhar, R., Thandavarayan, R. A., Karuppagounder, V., & Watanabe, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.010 · Cited by 37
Self-citationOxidative Stress and Heart Failure
Morrissy, S. J., & Chen, Q. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00711-9 · Cited by 37
Takahashi, K., Kamijo, Y., Hora, K., Hashimoto, K., Higuchi, M., Nakajima, T., Ehara, T., Shigematsu, H., Gonzalez, F. J., & Aoyama, T. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.02.012 · Cited by 37
Self-citationEctopic expression of Cdk8 induces eccentric hypertrophy and heart failure
Hall, D. D., Ponce, J., Chen, B., Spitler, K. M., Alexia, A., Oudit, G. Y., Song, L., & Grueter, C. E. (2017) · JCI Insight · doi:10.1172/jci.insight.92476 · Cited by 36
Wu, Q., Deng, W., Xiao, Y., Chen, J., Liu, C., Wang, J., Guo, Y., Duan, M., Cai, Z., Xie, S., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7536803 · Cited by 36
Standage, S. W., Waworuntu, R. L., Delaney, M. A., Maskal, S. M., Bennion, B. G., Duffield, J. S., Parks, W. C., Liles, W. C., & McGuire, J. K. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001585 · Cited by 35
Ding, L., Liang, X., Zhu, D., & Lou, Y. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.03.013 · Cited by 35
Iemitsu, M., Shimojo, N., Maeda, S., Irukayama‐Tomobe, Y., Sakai, S., Ohkubo, T., Tanaka, Y., & Miyauchi, T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01417.2006 · Cited by 33
Wang, X., Zhu, X., Jiao, S., Qi, D., Yu, B., Xie, G., Liu, Y., Song, Y., Xu, Q., Xu, Q., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00743-z · Cited by 33
Self-citationMyocardial Fatty Acid Metabolism and Lipotoxicity in the Setting of Insulin Resistance
Kok, B. P., & Brindley, D. N. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.008 · Cited by 32
Chen, X., Zeng, S., Zou, J., Chen, Y., Yue, Z., Gao, Y., Zhang, L., Cao, W., & Liu, P. (2014) · Mediators of Inflammation · doi:10.1155/2014/868753 · Cited by 32
Alterations in carbohydrate metabolism and its regulation in PPARα null mouse hearts
Gélinas, R., Labarthe, F., Bouchard, B., Duff, J. M., Charron, G., Young, M. E., & Rosiers, C. D. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01340.2007 · Cited by 32
The Potential Role of PPARs in the Fetal Origins of Adult Disease
Guo, J., Wu, J., He, Q., Zhang, M., Li, H., & Liu, Y. (2022) · Cells · doi:10.3390/cells11213474 · Cited by 31
Mitochondrial connection to ginsenosides
Wang, F., & Roh, Y. S. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01279-2 · Cited by 30
Multiple roles of PPARα in brown adipose tissue under constitutive and cold conditions
Komatsu, M., Tong, Y., Li, Y., Nakajima, T., Li, G., Hu, R., Sugiyama, E., Kamijo, Y., Tanaka, N., Hara, A., et al. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01368.x · Cited by 30
Self-citationTian, Q., Grzemski, F. A., Panagiotopoulos, S., & Ahokas, J. T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.02.003 · Cited by 30
PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways
Lecarpentier, Y., CLAES, V. A., & Hébert, J. (2010) · PPAR Research · doi:10.1155/2010/783273 · Cited by 29
Kawamoto, A., Kato, T., Shioi, T., Okuda, J., Kawashima, T., Tamaki, Y., Niizuma, S., Tanada, Y., Takemura, G., Narazaki, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117091 · Cited by 29
Liu, J., Wang, P., He, L., Li, Y., Luo, J., Cheng, L., Qin, Q., Brako, L. A., Lo, W.-K., Lewis, W., et al. (2011) · PPAR Research · doi:10.1155/2011/372854 · Cited by 29
Zuo, N., Zheng, X., Liu, H., & Ma, X. (2015) · PubMed · Cited by 29
Keshava, N., & Caldwell, J. C. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8693 · Cited by 29
Mitochondrial Dysfunction in the Cardio-Renal Axis
Méndez‐Barbero, N., Oller, J., Sanz, A. B., Ramos, A. M., Ortíz, A., Ruiz‐Ortega, M., & Rayego‐Mateos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098209 · Cited by 28
Rame, J. E., Barouch, L. A., Sack, M. N., Lynn, E. G., Abu-Asab, M. S., Tsokos, M., Kern, S. J., Barb, J. J., Munson, P. J., Halushka, M. K., et al. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00088.2010 · Cited by 30
New insights into the role of melatonin in diabetic cardiomyopathy
Huang, K., Luo, X., Zhong, Y., Deng, L., & Feng, J. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.904 · Cited by 27
Nakajima, T., Kamijo, Y., Huang, Y., Kimura, T., Tanaka, N., Sugiyama, E., Nakamura, K., Kyogashima, M., Hara, A., & Aoyama, T. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9454-6 · Cited by 26
Self-citationCentral leptin regulates heart lipid content by selectively increasing PPAR β/δ expression
Mora, C., Pintado, C., Rubio, B., Mazuecos, L., López, V., Fernández, A., Salamanca, A., Bárcena, B., Fernández‐Agulló, T., Arribas, C., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0554 · Cited by 27
Kotula‐Balak, M., Górowska-Wójtowicz, E., Milon, A., Pawlicki, P., Tworzydlo, W., Płachno, B. J., Krakowska, I., Hejmej, A., Wolski, J. K., & Bilińska, B. (2020) · PROTOPLASMA · doi:10.1007/s00709-020-01488-y · Cited by 26
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
Xu, S., Ma, Z., Wei, W., Yuan, Y., & Tang, Q. (2017) · PPAR Research · doi:10.1155/2017/5789714 · Cited by 25
PPARγ and NOTCH Regulate Regional Identity in the Murine Cardiac Outflow Tract
Rammah, M., Théveniau‐Ruissy, M., Sturny, R., Rochais, F., & Kelly, R. G. (2022) · Circulation Research · doi:10.1161/circresaha.122.320766 · Cited by 25
Wang, J., Gao, T., Wang, F., Xue, J., Ye, H., & Xie, M.-L. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.02.004 · Cited by 25
The Role of PPARδ Signaling in the Cardiovascular System
Ding, Y., Yang, K. D., & Yang, Q. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00014-4 · Cited by 25
Fujii, N., Nozawa, T., Igawa, A., Kato, B., Igarashi, N., Nonomura, M., Asanoi, H., Tazawa, S., Inoue, M., & Inoue, H. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00734.2003 · Cited by 25
Suppression of expression of muscle-associated proteins by PPARα in brown adipose tissue
Tong, Y., Hara, A., Komatsu, M., Tanaka, N., Kamijo, Y., Gonzalez, F. J., & Aoyama, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.041 · Cited by 25
Self-citationAtgl gene deletion predisposes to proximal tubule damage by impairing the fatty acid metabolism
Chen, W., Zhang, Q., Cheng, S., Huang, J., Diao, G., & Han, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.170 · Cited by 24
PPARα Is Necessary for Radiation-Induced Activation of Noncanonical TGFβ Signaling in the Heart
Subramanian, V., Borchard, S., Azimzadeh, O., Sievert, W., Merl‐Pham, J., Mancuso, M., Pasquali, E., Multhoff, G., Popper, B., Zischka, H., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00001 · Cited by 23
Pellieux, C., Montessuit, C., Papageorgiou, I., & Lerch, R. A. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0297-0 · Cited by 23
Bourdon, M., Santulli, P., Kateb, F., Pocate-Cheriet, K., Batteux, F., Maignien, C., Chouzenoux, S., Bordonné, C., Marcellin, L., Bertho, G., et al. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.02.031 · Cited by 22
Zhang, L., Chen, Y., Yue, Z., He, Y., Zou, J., Chen, S., Liu, M., Chen, X., Liu, Z., Liu, X., et al. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.005 · Cited by 22
Chen, W., Lai, Y., Wang, L., Xia, Y., Chen, W., Zhao, X., Mao-hua, Y., Li, Y., Zhang, Y., & Ye, H. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.007 · Cited by 22
Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats
Muroya, Y., Ito, O., Rong, R., Takashima, K., Ito, D., Cao, P., Nakamura, Y., Joh, K., & Kohzuki, M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00365.2011 · Cited by 22
ASAI, T., Okumura, K., TAKAHASHI, R., MATSUI, H., Numaguchi, Y., Murakami, H., Murakami, R., & Murohara, T. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.005 · Cited by 22
Peroxisome Proliferator-Activated Receptor ?? and Hypertensive Heart Disease
Goikoetxea, M. J., Beaumont, J., & ez, J. D. (2004) · Drugs · doi:10.2165/00003495-200464002-00003 · Cited by 22
Cabrero, À., Jové, M., Planavila, A., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.764 · Cited by 22
Metadata
- Authors
- Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., Kamijo, Y., Gonzalez, F. J., & Aoyama, T.
- Affiliations
- Niigata University of Pharmacy and Medical and Life Sciences (JP)
- Niigata University (JP)
- Shinshu University (JP)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 29
- Pages
- 22293-22299
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2099834627
- Cited by
- 314
- References
- 43
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 12 · 2020: 8 · 2019: 10 · 2018: 13 · 2017: 16 · 2016: 16 · 2015: 17 · 2014: 12 · 2013: 6 · 2012: 10
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7401 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PPARα, cardiac fatty acid metabolism, PPARalpha-null mice, fatty acid transporters, peroxisomal beta-oxidation, lignoceric acid, myocardial fibrosis, caveolae, mitochondrial cristae, nuclear receptors
- MeSH terms
- Aging, Animals, Fatty Acids, Myocardium, Nuclear Proteins, Oxidation-Reduction, Transcription Factors, Immunoblotting, Receptors, Cytoplasmic and Nuclear, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.